The role of serotonin in ischemic cellular damage and the infarct size-reducing effect of sarpogrelate, a 5-hydroxytryptamine-2 receptor blocker, in rabbit hearts
- 2 October 2002
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (7) , 1347-1355
- https://doi.org/10.1016/s0735-1097(02)02158-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining techniquePublished by Elsevier ,2004
- Role of protein kinase C in the reduction of infarct size by N‐methyl‐1‐deoxynojirimycin, an α‐1,6‐glucosidase inhibitorBritish Journal of Pharmacology, 2001
- A novel anti‐diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbitsBritish Journal of Pharmacology, 1999
- Protein Kinase C- ξ is Responsible for the Protection of Preconditioning in Rabbit CardiomyocytesJournal of Molecular and Cellular Cardiology, 1999
- Serotonin 5-HT2A Receptor Binding in Platelets from Healthy Subjects as Studied by [3H]-Lysergic Acid Diethylamide ([3H]-LSD): Intra- and Interindividual VariabilityNeuropsychopharmacology, 1997
- Protective Effect of the Serotonin Receptor Antagonist Cinanserin in Two Canine Models of Pacing-Induced Myocardial IschemiaPharmacology, 1995
- Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia.Circulation, 1994
- Protective Effect of Serotonin (5-HT2) Receptor Antagonists in Ischemic Rat HeartsJournal of Cardiovascular Pharmacology, 1993
- Differential regional responses of myocardial interstitial noradrenaline levels to coronary occlusionCardiovascular Research, 1993
- 5HT2-receptors and serotonin release: Their role in human platelet aggregationLife Sciences, 1993